Vanderbilt University
The Office of Technology Transfer and Enterprise Development (OTTED) plays the major role in protecting and preserving the intellectual property assets of Vanderbilt University, licensing technology developed by Vanderbilt inventors and innovators, and assisting in the start-up of companies which commercialize Vanderbilt technology. Through these activities, OTTED substantially benefits inventors, Vanderbilt University, its community, and the public at-large.
Innovations (222):
- Zebrafish Linkage Mapping Panel (25 JAN 10)
- Variants of Cyan Fluorescent Protein with Improved Fluorescent Properties (25 JAN 10)
- Use of Dexatromethorphan; Sodium Benzoate, Phenylacetate and Phenylbuterate to Treat Autism Associated with Increased Levels of Glutamine and Glycine. (25 JAN 10)
- Treatment & Prevention of Oxidative Injury (25 JAN 10)
- Tools and Methods for Selectively Sampling Blood Analytes (25 JAN 10)
- Therapeutic Antibodies for Pathologic Vasculature Driven Diseases (25 JAN 10)
- The Tumor Suppressor Killin (25 JAN 10)
- The Human Serotonin Transporter Gene (SLC6A4) is a Susceptibility Locus for Autism, Harbors Heterogeneous Functionally-Abnormal Alleles, and Confers Genetic Risk for Autism Spectrum Disorders in a Male-Biased Fashion (25 JAN 10)
- T4 Endonuclease V DNA Repair Enzyme (25 JAN 10)
- Substituted Dicinnamoylquinides and Their Use in Augmentation of Adenosine Function (25 JAN 10)
Find more innovations
